Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole versus megestrol for abnormal uterine bleeding with simple endometrial hyperplasia
IRCT2015031011504N5Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of letrozole and megestrol in endometrial hyperplasia (EH) and menstrual disorders (2 arms), sponsored by Semnan University of Medical Sciences. Started Jun 2015; status: completed.
02
Drugs
letrozolemegestrol
03
Conditions
endometrial hyperplasia (EH)menstrual disorders
Beyond the preview
Go deeper on IRCT2015031011504N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015031011504N5.